HIGHLIGHTS
- who: Sander De Bruyne and colleagues from the Department of Diagnostic Sciences, Ghent University, Ghent, Belgium have published the research work: Clinical Medicine, in the Journal: (JOURNAL) of 14/09/2018
- what: The study demonstrated for the first time a potential role of FN3K in the disruption of AGE-related retinal autofluorescence drusenoid material and drusenoid lesions in patients with AMD. The study showed that both in_vitro FN3K treatment of AGE-modified cofactors in the treatment of AMD.
SUMMARY
Age-related macular degeneration (AMD) is a degenerative disorder of the macular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.